SCHEMBL8497944

SCHEMBL8497944

NC(N)(Cc1ccc2c(c1)OCO2)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.58
ALDH1A1 P00352 3/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2C19 P33261 1/20 0.58
TAAR1 Q96RJ0 3/20 0.51
SLC6A4 P31645 2/20 0.50
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
HPGD P15428 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
MAPK1 P28482 1/20 0.49
TRPM8 Q7Z2W7 1/20 0.48
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
CMA1 P23946 1/20 0.47
CYP2D6 P10635 1/20 0.47
SLC13A5 Q86YT5 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6718864 0.86 CYP3A4 (0.57) CYP3A4ALDH1A1CYP1A2CYP2C19TAAR1
SCHEMBL13957646 0.86 CYP3A4 (0.57) CYP3A4ALDH1A1CYP1A2CYP2C19TAAR1
SCHEMBL8871858 0.85 CYP3A4 (0.59) CYP3A4ALDH1A1CYP1A2CYP2C19TAAR1
SCHEMBL1717641 0.83 CYP3A4 (0.56) CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A
SCHEMBL3099172 0.83 CYP3A4 (0.56) CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A
SCHEMBL10576319 0.81 ALDH1A1 (0.48) CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A
SCHEMBL10576326 0.81 ALDH1A1 (0.48) CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A
SCHEMBL27969667 0.79 ALDH1A1 (0.52) CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A
SCHEMBL28566695 0.79 CYP3A4 (0.48) CYP3A4ALDH1A1CYP1A2CYP2C19TAAR1
SCHEMBL9361284 0.78 TAAR1 (0.56) CYP3A4ALDH1A1CYP1A2TAAR1SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5872122-A Pyrimidinylamidino β-amino acid derivatives useful as inhibitors of platelet aggregation MONSANTO COMPANY (US) 1999-02-16 US disclosed